Favillini Pharmaceutical Packaging Group has acquired Interpack S.p.A., supported by New Deal Advisors, to enhance its market position in the Italian pharmaceutical and nutraceutical packaging sectors.
Target Information
Favillini Pharmaceutical Packaging Group S.p.A., an Italian company renowned for its specialization in secondary packaging for the pharmaceutical and nutraceutical sectors, has successfully acquired Interpack S.p.A. This acquisition was facilitated by New Deal Advisors, an independent advisory firm with expertise in extraordinary transactions. Favillini is controlled by Arcadia Sgr and has embarked on a strategy of both organic growth and external acquisitions since 2020 to consolidate the fragmented Italian market for pharmaceutical packaging.
Interpack S.p.A., based in Pomezia and under the ownership of Oxy Capital through Gpack, specializes in producing packaging materials tailored for the pharmaceutical industry. With this integration, Favillini reinforces its market presence as a leader in secondary packaging for pharmaceuticals and nutraceuticals, aiming to achieve a consolidated revenue exceeding €45 million in 2025, facilitated by three production facilities and an expected annual output of approximately 850 million pieces.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The pharmaceutical packaging industry in Italy is characterized by a substantial growth trajectory, driven by increasing regulatory requirements and the rising demand for advanced packaging solutions. As the healthcare sector in Italy continues to expand,
Similar Deals
Favillini Pharmaceutical Packaging Group S.p.A.
invested in
Interpack S.p.A.
in 2025
in a Other deal
Disclosed details
Revenue: $49M